Abnormal Hematopoiesis, Allogenic Disease, Graft vs Host Disease
Conditions
Keywords
myelosuppression, mesenchymal stromal cells
Brief summary
The objective is to measure the frequency, functionality and phenotype of bone marrow-derived mesenchymal stromal cells in patients after allogeneic hematopoietic stem cell transplantation. Furthermore, the immune cell infiltrate of the bone marrow will be monitored at the same time. These results will be correlated with the extent of cytopenia and clinical graft-versus-host disease grading.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* age \>18 * acute myeloid leukemia * myelodysplastic syndrome * hematopoietic stem cell transplantation
Exclusion criteria
* not willing to take part
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the amount of mesenchymal stromal cells after allogeneic hematopoietic stem cell transplantation | up to 1 year after allogeneic hematopoietic stem cell transplantation |
Countries
Germany